Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
CEO | Mr. Michael J. Parini J.D. |
IPO Date | Aug. 7, 2020 |
Location | United Kingdom |
Headquarters | Stevenage Bioscience Catalyst, Stevenage, United Kingdom, SG1 2FX |
Employees | 152 |
Sector | Healthcare |
Industry | Biotechnology |
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies. It develops FLT180a for the treatment of hemophilia B.; FLT201 for the treatment of Type 1 Gaucher disease; and FLT190 for the treatment of Fabry disease. in addition, it has research programs for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.
NA
NA
NA
StockViz Staff
September 21, 2024
Any question? Send us an email